N
0IK
vs
JNJ
JNJ
Over the past 12 months, 0IK has outperformed JNJ, delivering a return of +71% compared to the JNJ's +55% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
JNJ
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
N
|
NGM Biopharmaceuticals Inc
F:0IK
|
5.62
EUR
|
|||||
|
Johnson & Johnson
NYSE:JNJ
|
237.96
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
0IK, JNJ
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
N
|
NGM Biopharmaceuticals Inc
Revenue
|
|||||||||||
|
Johnson & Johnson
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
0IK, JNJ
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
N
|
NGM Biopharmaceuticals Inc
F:0IK
|
|||||||||
|
Johnson & Johnson
NYSE:JNJ
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
NGM Biopharmaceuticals Inc | ||||
|
Johnson & Johnson | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
NGM Biopharmaceuticals Inc | ||||
|
Johnson & Johnson | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
NGM Biopharmaceuticals Inc | ||||
|
Johnson & Johnson | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
NGM Biopharmaceuticals Inc | ||||
|
Johnson & Johnson | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
0IK, JNJ
Performance By Year
0IK, JNJ
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|